Compassionate Use Study of Tenalisib (RP6530)
Clinical trial NCT03711604 · COMPLETED
Trial details
- NCT number
- NCT03711604
- Sponsor
- Rhizen Pharmaceuticals SA
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2023-03-25
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.